Endomag is a global medical technology business headquartered in Cambridge, United Kingdom. They specialise in creating products that improve staging and treatment of breast cancer, including the Sentimag® system, Magseed® magnetic marker and Magtrace® lymphatic tracer.

Their products have now been used in surgical procedures for over 100,000 patients worldwide, in 500+ hospitals across 40+ countries and their mission is simple – to make better breast cancer care available to everyone.

For further information, visit www.endomag.com